Press Releases & Presentations

Press Releases & Presentations

Date Title and Summary Additional Formats
Toggle Summary Accelerate Diagnostics Reports 191 Instruments Under Contract and 3x Revenue Growth for First Quarter 2017
TUCSON, Ariz. , May 03, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced preliminary financial results for the quarter ending March 31, 2017 including signed customer evaluation contracts covering 169 instruments, 22 additional instruments converted into revenue generating Read more
View HTML
Toggle Summary Accelerate Diagnostics Schedules Call to Review First Quarter 2017 Results for May 3rd
TUCSON, Ariz. , April 18, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Wednesday, May 3 rd , 2017 to discuss its first quarter 2017 financial results and commercial progress. President and Chief Executive Officer, Lawrence Mehren , joined Read more
View HTML
Toggle Summary Accelerate Diagnostics Names Tom Brown to Board of Directors
TUCSON, Ariz. , March 15, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced the election of Tom Brown to the company's board of directors. His appointment is effective March 14, 2017 . Brown's appointment adds over 30 years of medical diagnostics expertise to the company's board Read more
View HTML
Toggle Summary Accelerate Diagnostics Receives FDA Marketing Authorization for the Accelerate Pheno™ System and Accelerate PhenoTest™ BC Kit
First fully automated solution permitted by the FDA for quantitative antibiotic susceptibility testing directly from patient samples Read more
View HTML
Toggle Summary Accelerate Diagnostics to Report Preliminary Fourth Quarter and Full Year 2016 Results on February 27th
TUCSON, Ariz. , Feb. 23, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced it will report preliminary fourth-quarter and full year 2016 financial results on Monday, February 27 th , 2017. President and Chief Executive Officer, Lawrence Mehren , joined by Steve Reichling , Chief Read more
View HTML
Toggle Summary Accelerate Diagnostics to Present at the 35th Annual J.P. Morgan Healthcare Conference
TUCSON, Ariz. , Dec. 14, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that it will present at the 35 th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 11, 2017 at 11:00 a.m. PT . A live audio webcast of the presentation will be Read more
View HTML
Toggle Summary Accelerate Diagnostics to Present at the Piper Jaffray 28th Annual Healthcare Conference on November 30th
TUCSON, Ariz. , Nov. 22, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that Lawrence Mehren , President and Chief Executive Officer, is scheduled to present at the Piper Jaffray 28th Annual Healthcare Conference in New York City , NY on Wednesday, November 30th at 2:00 PM Read more
View HTML
Toggle Summary Accelerate Diagnostics to Report Third-Quarter 2016 Results on November 9th
TUCSON, Ariz. , Oct. 21, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will report third-quarter 2016 financial results on Wednesday, November 9, 2016 . President and Chief Executive Officer, Lawrence Mehren , joined by Steve Reichling , Chief Financial Officer, will host Read more
View HTML
Toggle Summary Accelerate Diagnostics to Report Second-Quarter 2016 Results on August 8
TUCSON, Ariz. , July 22, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will report second-quarter 2016 financial results on Monday, August 8 th . President and Chief Executive Officer, Lawrence Mehren , joined by Steve Reichling , Chief Financial Officer, will host a Read more
View HTML
Toggle Summary Accelerate Diagnostics Submits De Novo Request to FDA for Accelerate Pheno™ System and Accelerate PhenoTest™ BC kit
TUCSON, Ariz. , July 11, 2016 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. ("Accelerate") announced today the submission of a De Novo request for Evaluation of Automatic Class III Designation to the U.S. Food and Drug Administration (FDA) for its Accelerate Pheno™ system and Accelerate Read more
View HTML
:

Day High:
Day Low:  
Volume:    

Copyright West LLC. Minimum 15 minutes delayed.


Want to receive investor-related news and updates?

Join our mailing list

Other updates